患有缺血性额外外的患者的治疗策略:系统性审查和元分析
Qi Li1,2, Meiling Liang1, Mingyou Gao3
1Department of Cardiology, Fuwai Shenzhen Hospital, Chinese Academy of Medical Sciences, Shenzhen, Guangdong, P.R. China.
International journal of surgery (London, England)
|August 12, 2025
概括
冠状动脉旁路移植与心肌置换 (CABG + MVR) 为缺血性心肌吐 (IMR) 提供更好的长期生存,但风险更高. 穿皮冠状动脉干预 (PCI) 单独或与跨导管端到端修复 (TEER) 有不同的结果.
科学领域:
- 心血管医学 心血管医学
- 干预心脏病学 干预心脏病学
- 心脏外科手术 心脏外科手术
背景情况:
- 缺血性 mitrale 吐 (IMR) 的管理包括冠状动脉旁路移植与 mitrale 置换 (CABG + MVR),皮肤冠状动脉干预 (PCI) 单独,或PCI与跨导管边缘到边缘修复 (TEER).
- 对这些IMR治疗策略的比较证据有限.
研究的目的:
- 系统地评估和比较CABG + MVR,单独的PCI和IMR的PCI + TEER的术后特征,住院和长期结果.
主要方法:
- 一个符合PRISMA 2020的系统审查和对报告IMR治疗结果的研究的元分析.
- 搜索主要数据库到2024年11月12日,包括随机对照试验和队列研究.
- 使用随机效应模型汇集数据来分析死亡率,程序指标,住院和并发症.
主要成果:
- 分析了33项与3,001名患者的研究; CABG + MVR显示优越的5年生存率 (37.5%) 与PCI (41.8%).
- 与CABG + MVR (11.8%) 和PCI (9.4%) 相比,PCI + TEER的住院时间较短 (17.3天),但住院死亡率较高 (13.8%).
- CABG + MVR具有较高的脑血管事件 (4.1%),心房动 (22.9%) 和低心输出综合征 (19.6%) 的比率.
结论:
- CABG + MVR提供了更好的长期存活率,但增加了IMR的术后风险和并发症.
- PCI + TEER证明了更短的住院时间,尽管长期疗效需要进一步研究.
- 最佳的IMR治疗选择需要多学科的决策,平衡患者的并发症,手术风险和MR严重程度,需要强大的比较试验.
相关概念视频
01:25Mitral Regurgitation III: Medical Management
30
Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
30
01:26Mitral Stenosis III: Medical Management
21
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
21
01:28Mitral Regurgitation IV: Nursing Management
82
Mitral regurgitation (MR) is a condition where the mitral valve does not close properly, leading to the backward flow of blood from the left ventricle into the left atrium during systole. This condition can arise from various causes, including rheumatic fever, infective endocarditis, or degenerative valve disease. Effective nursing management is crucial to optimizing patient outcomes and involves comprehensive assessment and targeted interventions.Comprehensive Patient AssessmentA detailed...
82
01:25Aortic Regurgitation III: Medical Management
43
Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
43
01:27Mitral Stenosis IV: Nursing Management
46
A comprehensive nursing assessment is essential for patients with valvular heart disease, which involves any dysfunction of the heart valves that could impact blood flow and overall heart function.Subjective Data Collection:Chief Complaint and Present Illness: Start with the patient's primary concerns, focusing on the onset, duration, and progression of cardiac symptoms such as dyspnea, fatigue, chest pain, and palpitations.Past Medical History: Collect detailed information on any previous...
46
01:22Mitral Valve Prolapse II: Assessment and Management
39
IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular...
39